Predictors of All-Cause 1-Year Mortality in Implantable Cardioverter Defibrillator Patients with Chronic Chagas' Cardiomyopathy
Background: Implantable cardioverter defibrillators (ICDs) have been used in the treatment of either sustained ventricular tachycardia or ventricular fibrillation in patients with Chagas’ cardiomyopathy. This study aimed at determining mortality rate and risk factors of all‐cause 1‐year mortality in...
Gespeichert in:
| Veröffentlicht in: | Pacing and clinical electrophysiology 2011-09, Vol.34 (9), p.1063-1069 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1069 |
|---|---|
| container_issue | 9 |
| container_start_page | 1063 |
| container_title | Pacing and clinical electrophysiology |
| container_volume | 34 |
| creator | TORO, DARÍO DI MURATORE, CLAUDIO AGUINAGA, LUIS BATISTA, LUIZ MALAN, ANTONIO GRECO, OSWALDO BENCHETRIT, CHAMIA DUQUE, MAURICIO BARANCHUK, ADRIAN MALONEY, JENNIFER |
| description | Background: Implantable cardioverter defibrillators (ICDs) have been used in the treatment of either sustained ventricular tachycardia or ventricular fibrillation in patients with Chagas’ cardiomyopathy. This study aimed at determining mortality rate and risk factors of all‐cause 1‐year mortality in primary and secondary ICD patients with Chagas’ cardiomyopathy.
Methods: One hundred and forty‐eight Chagas’ patients with ICDs were included from the Medtronic ICD Registry Latin America. All patients were followed for 1 year.
Results: At implant, mean age was 60.1 ± 9.4 years and 72.9% were male. Mean left ventricular ejection fraction (LVEF) was 40.1 ± 11%. Mean follow‐up was 12 ± 7 months. During the follow‐up, 15 patients died (10.2%). Patients who died were older (64 ±10.8 years vs 59 ± 9.1; P = 0.04), had more atrial fibrillation (13.3% vs 3.8%; P = 0.02), had lower LVEF (33.4%± 9.8 vs 40.9%± 11.3; P = 0.01), and worse functional class (III/IV 40% vs 21.8%; P = 0.03). The multivariate analysis showed that two independent predictors of all‐cause 1‐year mortality remained statistically significant: age more than 65 (hazard ratio [HR] = 2.85, 95% confidence interval [CI] 1.77–3.92; P = 0.03) and LVEF less than 30% (HR = 2.68, 95% CI 1.57–3.79; P = 0.04).
Conclusion: This analysis showed that patients older than 65 years of age and with LVEF less than 30% were independent predictors of all‐cause 1‐year mortality in patients with chronic Chagas’ cardiomyopathy. (PACE 2011; 34:1063–1069) |
| doi_str_mv | 10.1111/j.1540-8159.2011.03108.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_898503906</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>898503906</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5208-e1ad7838b21c397d82a64efcc6ada77cc31909ae5cfae1425b23a5852efeaea73</originalsourceid><addsrcrecordid>eNqNkU-P0zAQxSMEYsvCV0C-oOWSYCdx4lyQutk_LOxCDyDEyZo6E-riJMV22ebEV8ehpdwQvoyl-b03Y78oIowmLJxX64TxnMaC8SpJKWMJzRgVye5BNDs2HkYzyvIyFpmoTqInzq0ppQXN-ePoJGU840Ezi34uLDZa-cE6MrRkbkxcw9YhYfEXBEvuBuvBaD8S3ZObbmOg97A0SGqwjR5-oPVoyQW2emm1MRCMyAK8xt47cq_9itQrO_RahQpfwZ0dhN04bMCvxqfRoxaMw2eHehp9urr8WL-Jbz9c39Tz21jxlIoYGTRleMkyZSqrykakUOTYKlVAA2WpVMYqWgFy1QKyPOXLNAMueIotAkKZnUZne9-NHb5v0XnZaacwbNzjsHVSVCJ8SEWLQL78J8loKmhZVCwPqNijyg7OWWzlxuoO7BggOQUl13LKQ055yCko-TsouQvS54cp22WHzVH4J5kAvDgA4BSY1kKvtPvL5ZzSLK0C93rP3WuD438vIBfz-nK6BoN4b6Cdx93RAOw3WZRZyeXn99fy4vztnbhavJMs-wXVmr8w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1028076914</pqid></control><display><type>article</type><title>Predictors of All-Cause 1-Year Mortality in Implantable Cardioverter Defibrillator Patients with Chronic Chagas' Cardiomyopathy</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>TORO, DARÍO DI ; MURATORE, CLAUDIO ; AGUINAGA, LUIS ; BATISTA, LUIZ ; MALAN, ANTONIO ; GRECO, OSWALDO ; BENCHETRIT, CHAMIA ; DUQUE, MAURICIO ; BARANCHUK, ADRIAN ; MALONEY, JENNIFER</creator><creatorcontrib>TORO, DARÍO DI ; MURATORE, CLAUDIO ; AGUINAGA, LUIS ; BATISTA, LUIZ ; MALAN, ANTONIO ; GRECO, OSWALDO ; BENCHETRIT, CHAMIA ; DUQUE, MAURICIO ; BARANCHUK, ADRIAN ; MALONEY, JENNIFER</creatorcontrib><description>Background: Implantable cardioverter defibrillators (ICDs) have been used in the treatment of either sustained ventricular tachycardia or ventricular fibrillation in patients with Chagas’ cardiomyopathy. This study aimed at determining mortality rate and risk factors of all‐cause 1‐year mortality in primary and secondary ICD patients with Chagas’ cardiomyopathy.
Methods: One hundred and forty‐eight Chagas’ patients with ICDs were included from the Medtronic ICD Registry Latin America. All patients were followed for 1 year.
Results: At implant, mean age was 60.1 ± 9.4 years and 72.9% were male. Mean left ventricular ejection fraction (LVEF) was 40.1 ± 11%. Mean follow‐up was 12 ± 7 months. During the follow‐up, 15 patients died (10.2%). Patients who died were older (64 ±10.8 years vs 59 ± 9.1; P = 0.04), had more atrial fibrillation (13.3% vs 3.8%; P = 0.02), had lower LVEF (33.4%± 9.8 vs 40.9%± 11.3; P = 0.01), and worse functional class (III/IV 40% vs 21.8%; P = 0.03). The multivariate analysis showed that two independent predictors of all‐cause 1‐year mortality remained statistically significant: age more than 65 (hazard ratio [HR] = 2.85, 95% confidence interval [CI] 1.77–3.92; P = 0.03) and LVEF less than 30% (HR = 2.68, 95% CI 1.57–3.79; P = 0.04).
Conclusion: This analysis showed that patients older than 65 years of age and with LVEF less than 30% were independent predictors of all‐cause 1‐year mortality in patients with chronic Chagas’ cardiomyopathy. (PACE 2011; 34:1063–1069)</description><identifier>ISSN: 0147-8389</identifier><identifier>EISSN: 1540-8159</identifier><identifier>DOI: 10.1111/j.1540-8159.2011.03108.x</identifier><identifier>PMID: 21535031</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>Aged ; Atrial Fibrillation - mortality ; Atrial Fibrillation - physiopathology ; Atrial Fibrillation - therapy ; Biological and medical sciences ; Cardiology. Vascular system ; Chagas Cardiomyopathy - mortality ; Chagas Cardiomyopathy - physiopathology ; Chagas Cardiomyopathy - therapy ; Chagas' cardiomyopathy ; Chronic Disease ; Cohort Studies ; Death, Sudden, Cardiac - epidemiology ; Defibrillators, Implantable - adverse effects ; Diseases of the cardiovascular system ; Female ; Follow-Up Studies ; Heart ; Humans ; implantable cardioverter defibrillator ; Latin America - epidemiology ; Male ; Medical sciences ; Middle Aged ; mortality ; Myocarditis. Cardiomyopathies ; Prognosis ; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) ; Treatment Outcome ; Ventricular Dysfunction, Left - mortality ; Ventricular Dysfunction, Left - physiopathology</subject><ispartof>Pacing and clinical electrophysiology, 2011-09, Vol.34 (9), p.1063-1069</ispartof><rights>2011, The Authors. Journal compilation ©2011 Wiley Periodicals, Inc.</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5208-e1ad7838b21c397d82a64efcc6ada77cc31909ae5cfae1425b23a5852efeaea73</citedby><cites>FETCH-LOGICAL-c5208-e1ad7838b21c397d82a64efcc6ada77cc31909ae5cfae1425b23a5852efeaea73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1540-8159.2011.03108.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1540-8159.2011.03108.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24500329$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21535031$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TORO, DARÍO DI</creatorcontrib><creatorcontrib>MURATORE, CLAUDIO</creatorcontrib><creatorcontrib>AGUINAGA, LUIS</creatorcontrib><creatorcontrib>BATISTA, LUIZ</creatorcontrib><creatorcontrib>MALAN, ANTONIO</creatorcontrib><creatorcontrib>GRECO, OSWALDO</creatorcontrib><creatorcontrib>BENCHETRIT, CHAMIA</creatorcontrib><creatorcontrib>DUQUE, MAURICIO</creatorcontrib><creatorcontrib>BARANCHUK, ADRIAN</creatorcontrib><creatorcontrib>MALONEY, JENNIFER</creatorcontrib><title>Predictors of All-Cause 1-Year Mortality in Implantable Cardioverter Defibrillator Patients with Chronic Chagas' Cardiomyopathy</title><title>Pacing and clinical electrophysiology</title><addtitle>Pacing Clin Electrophysiol</addtitle><description>Background: Implantable cardioverter defibrillators (ICDs) have been used in the treatment of either sustained ventricular tachycardia or ventricular fibrillation in patients with Chagas’ cardiomyopathy. This study aimed at determining mortality rate and risk factors of all‐cause 1‐year mortality in primary and secondary ICD patients with Chagas’ cardiomyopathy.
Methods: One hundred and forty‐eight Chagas’ patients with ICDs were included from the Medtronic ICD Registry Latin America. All patients were followed for 1 year.
Results: At implant, mean age was 60.1 ± 9.4 years and 72.9% were male. Mean left ventricular ejection fraction (LVEF) was 40.1 ± 11%. Mean follow‐up was 12 ± 7 months. During the follow‐up, 15 patients died (10.2%). Patients who died were older (64 ±10.8 years vs 59 ± 9.1; P = 0.04), had more atrial fibrillation (13.3% vs 3.8%; P = 0.02), had lower LVEF (33.4%± 9.8 vs 40.9%± 11.3; P = 0.01), and worse functional class (III/IV 40% vs 21.8%; P = 0.03). The multivariate analysis showed that two independent predictors of all‐cause 1‐year mortality remained statistically significant: age more than 65 (hazard ratio [HR] = 2.85, 95% confidence interval [CI] 1.77–3.92; P = 0.03) and LVEF less than 30% (HR = 2.68, 95% CI 1.57–3.79; P = 0.04).
Conclusion: This analysis showed that patients older than 65 years of age and with LVEF less than 30% were independent predictors of all‐cause 1‐year mortality in patients with chronic Chagas’ cardiomyopathy. (PACE 2011; 34:1063–1069)</description><subject>Aged</subject><subject>Atrial Fibrillation - mortality</subject><subject>Atrial Fibrillation - physiopathology</subject><subject>Atrial Fibrillation - therapy</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Chagas Cardiomyopathy - mortality</subject><subject>Chagas Cardiomyopathy - physiopathology</subject><subject>Chagas Cardiomyopathy - therapy</subject><subject>Chagas' cardiomyopathy</subject><subject>Chronic Disease</subject><subject>Cohort Studies</subject><subject>Death, Sudden, Cardiac - epidemiology</subject><subject>Defibrillators, Implantable - adverse effects</subject><subject>Diseases of the cardiovascular system</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart</subject><subject>Humans</subject><subject>implantable cardioverter defibrillator</subject><subject>Latin America - epidemiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>mortality</subject><subject>Myocarditis. Cardiomyopathies</subject><subject>Prognosis</subject><subject>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</subject><subject>Treatment Outcome</subject><subject>Ventricular Dysfunction, Left - mortality</subject><subject>Ventricular Dysfunction, Left - physiopathology</subject><issn>0147-8389</issn><issn>1540-8159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU-P0zAQxSMEYsvCV0C-oOWSYCdx4lyQutk_LOxCDyDEyZo6E-riJMV22ebEV8ehpdwQvoyl-b03Y78oIowmLJxX64TxnMaC8SpJKWMJzRgVye5BNDs2HkYzyvIyFpmoTqInzq0ppQXN-ePoJGU840Ezi34uLDZa-cE6MrRkbkxcw9YhYfEXBEvuBuvBaD8S3ZObbmOg97A0SGqwjR5-oPVoyQW2emm1MRCMyAK8xt47cq_9itQrO_RahQpfwZ0dhN04bMCvxqfRoxaMw2eHehp9urr8WL-Jbz9c39Tz21jxlIoYGTRleMkyZSqrykakUOTYKlVAA2WpVMYqWgFy1QKyPOXLNAMueIotAkKZnUZne9-NHb5v0XnZaacwbNzjsHVSVCJ8SEWLQL78J8loKmhZVCwPqNijyg7OWWzlxuoO7BggOQUl13LKQ055yCko-TsouQvS54cp22WHzVH4J5kAvDgA4BSY1kKvtPvL5ZzSLK0C93rP3WuD438vIBfz-nK6BoN4b6Cdx93RAOw3WZRZyeXn99fy4vztnbhavJMs-wXVmr8w</recordid><startdate>201109</startdate><enddate>201109</enddate><creator>TORO, DARÍO DI</creator><creator>MURATORE, CLAUDIO</creator><creator>AGUINAGA, LUIS</creator><creator>BATISTA, LUIZ</creator><creator>MALAN, ANTONIO</creator><creator>GRECO, OSWALDO</creator><creator>BENCHETRIT, CHAMIA</creator><creator>DUQUE, MAURICIO</creator><creator>BARANCHUK, ADRIAN</creator><creator>MALONEY, JENNIFER</creator><general>Blackwell Publishing Inc</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>C1K</scope><scope>F1W</scope><scope>FR3</scope><scope>H95</scope><scope>H97</scope><scope>L.G</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201109</creationdate><title>Predictors of All-Cause 1-Year Mortality in Implantable Cardioverter Defibrillator Patients with Chronic Chagas' Cardiomyopathy</title><author>TORO, DARÍO DI ; MURATORE, CLAUDIO ; AGUINAGA, LUIS ; BATISTA, LUIZ ; MALAN, ANTONIO ; GRECO, OSWALDO ; BENCHETRIT, CHAMIA ; DUQUE, MAURICIO ; BARANCHUK, ADRIAN ; MALONEY, JENNIFER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5208-e1ad7838b21c397d82a64efcc6ada77cc31909ae5cfae1425b23a5852efeaea73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Aged</topic><topic>Atrial Fibrillation - mortality</topic><topic>Atrial Fibrillation - physiopathology</topic><topic>Atrial Fibrillation - therapy</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Chagas Cardiomyopathy - mortality</topic><topic>Chagas Cardiomyopathy - physiopathology</topic><topic>Chagas Cardiomyopathy - therapy</topic><topic>Chagas' cardiomyopathy</topic><topic>Chronic Disease</topic><topic>Cohort Studies</topic><topic>Death, Sudden, Cardiac - epidemiology</topic><topic>Defibrillators, Implantable - adverse effects</topic><topic>Diseases of the cardiovascular system</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart</topic><topic>Humans</topic><topic>implantable cardioverter defibrillator</topic><topic>Latin America - epidemiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>mortality</topic><topic>Myocarditis. Cardiomyopathies</topic><topic>Prognosis</topic><topic>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</topic><topic>Treatment Outcome</topic><topic>Ventricular Dysfunction, Left - mortality</topic><topic>Ventricular Dysfunction, Left - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TORO, DARÍO DI</creatorcontrib><creatorcontrib>MURATORE, CLAUDIO</creatorcontrib><creatorcontrib>AGUINAGA, LUIS</creatorcontrib><creatorcontrib>BATISTA, LUIZ</creatorcontrib><creatorcontrib>MALAN, ANTONIO</creatorcontrib><creatorcontrib>GRECO, OSWALDO</creatorcontrib><creatorcontrib>BENCHETRIT, CHAMIA</creatorcontrib><creatorcontrib>DUQUE, MAURICIO</creatorcontrib><creatorcontrib>BARANCHUK, ADRIAN</creatorcontrib><creatorcontrib>MALONEY, JENNIFER</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Engineering Research Database</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Pacing and clinical electrophysiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TORO, DARÍO DI</au><au>MURATORE, CLAUDIO</au><au>AGUINAGA, LUIS</au><au>BATISTA, LUIZ</au><au>MALAN, ANTONIO</au><au>GRECO, OSWALDO</au><au>BENCHETRIT, CHAMIA</au><au>DUQUE, MAURICIO</au><au>BARANCHUK, ADRIAN</au><au>MALONEY, JENNIFER</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictors of All-Cause 1-Year Mortality in Implantable Cardioverter Defibrillator Patients with Chronic Chagas' Cardiomyopathy</atitle><jtitle>Pacing and clinical electrophysiology</jtitle><addtitle>Pacing Clin Electrophysiol</addtitle><date>2011-09</date><risdate>2011</risdate><volume>34</volume><issue>9</issue><spage>1063</spage><epage>1069</epage><pages>1063-1069</pages><issn>0147-8389</issn><eissn>1540-8159</eissn><abstract>Background: Implantable cardioverter defibrillators (ICDs) have been used in the treatment of either sustained ventricular tachycardia or ventricular fibrillation in patients with Chagas’ cardiomyopathy. This study aimed at determining mortality rate and risk factors of all‐cause 1‐year mortality in primary and secondary ICD patients with Chagas’ cardiomyopathy.
Methods: One hundred and forty‐eight Chagas’ patients with ICDs were included from the Medtronic ICD Registry Latin America. All patients were followed for 1 year.
Results: At implant, mean age was 60.1 ± 9.4 years and 72.9% were male. Mean left ventricular ejection fraction (LVEF) was 40.1 ± 11%. Mean follow‐up was 12 ± 7 months. During the follow‐up, 15 patients died (10.2%). Patients who died were older (64 ±10.8 years vs 59 ± 9.1; P = 0.04), had more atrial fibrillation (13.3% vs 3.8%; P = 0.02), had lower LVEF (33.4%± 9.8 vs 40.9%± 11.3; P = 0.01), and worse functional class (III/IV 40% vs 21.8%; P = 0.03). The multivariate analysis showed that two independent predictors of all‐cause 1‐year mortality remained statistically significant: age more than 65 (hazard ratio [HR] = 2.85, 95% confidence interval [CI] 1.77–3.92; P = 0.03) and LVEF less than 30% (HR = 2.68, 95% CI 1.57–3.79; P = 0.04).
Conclusion: This analysis showed that patients older than 65 years of age and with LVEF less than 30% were independent predictors of all‐cause 1‐year mortality in patients with chronic Chagas’ cardiomyopathy. (PACE 2011; 34:1063–1069)</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>21535031</pmid><doi>10.1111/j.1540-8159.2011.03108.x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0147-8389 |
| ispartof | Pacing and clinical electrophysiology, 2011-09, Vol.34 (9), p.1063-1069 |
| issn | 0147-8389 1540-8159 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_898503906 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Aged Atrial Fibrillation - mortality Atrial Fibrillation - physiopathology Atrial Fibrillation - therapy Biological and medical sciences Cardiology. Vascular system Chagas Cardiomyopathy - mortality Chagas Cardiomyopathy - physiopathology Chagas Cardiomyopathy - therapy Chagas' cardiomyopathy Chronic Disease Cohort Studies Death, Sudden, Cardiac - epidemiology Defibrillators, Implantable - adverse effects Diseases of the cardiovascular system Female Follow-Up Studies Heart Humans implantable cardioverter defibrillator Latin America - epidemiology Male Medical sciences Middle Aged mortality Myocarditis. Cardiomyopathies Prognosis Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Treatment Outcome Ventricular Dysfunction, Left - mortality Ventricular Dysfunction, Left - physiopathology |
| title | Predictors of All-Cause 1-Year Mortality in Implantable Cardioverter Defibrillator Patients with Chronic Chagas' Cardiomyopathy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T22%3A58%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictors%20of%20All-Cause%201-Year%20Mortality%20in%20Implantable%20Cardioverter%20Defibrillator%20Patients%20with%20Chronic%20Chagas'%20Cardiomyopathy&rft.jtitle=Pacing%20and%20clinical%20electrophysiology&rft.au=TORO,%20DAR%C3%8DO%20DI&rft.date=2011-09&rft.volume=34&rft.issue=9&rft.spage=1063&rft.epage=1069&rft.pages=1063-1069&rft.issn=0147-8389&rft.eissn=1540-8159&rft_id=info:doi/10.1111/j.1540-8159.2011.03108.x&rft_dat=%3Cproquest_cross%3E898503906%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1028076914&rft_id=info:pmid/21535031&rfr_iscdi=true |